The US FDA has released its latest batch of product-specific guidance's, posting 19 new and 17 revised draft guidance's, bringing the total number of product-specific guidance's issued by the agency to 1,938. The guidance's, which FDA post

Unless you have an arcane disorder from a lesion on a very specific spot on our medulla, the chances are you sneeze. Turns out most animals do it, even lizards! Learn the whys and hows of this most interesting involuntary reflex. 

Scientists have discovered a previously unknown way that some bacteria produce the chemical ethylene -- a finding that could lead to new ways to produce plastics without using fossil fuels. The study, published this week in the journal Sci

Cassiopea has won approval for its first medicine, an acne treatment, from the U.S. FDA, setting the stage for a likely capital increase to support its launch. Winlevi, a twice-daily topical prescription medicine that targets hormones call

In addition to all the lousy things that's come out of the Coronavirus pandemic, the U.S. is also experiencing a coin shortage thanks to a stalled-out economic system that normally circulates coins. 

CPI has signed partnership agreements with Siemens plc, Perceptive Engineering LTD and Process Systems Enterprise LTD (PSE), making them a part of the Medicines Manufacturing Innovation Center collaboration. The partnership agreements will

Regeneron has announced plans to expand operations at its site in Limerick, Ireland adding roughly 400 new jobs. The expansion is a result of a decision to prepare Regeneron's plant in New York to produce a potential new antibody-based tre

There's a movement afoot that says we should all stop thinking about our weight and just enjoy food. No, it doesn't help you lose weight...No, it's not a diet...No, - just listen to the episode, okay? 

Amgen has licensed out an experimental heart disease drug to a newly formed biotech called NewAmsterdam Pharma. The drug, obicetrapib, was acquired by Amgen when it purchased Dezima in 2015 but the drug was shelved two years later. Some fo

With over 170,000 COVID-19 deaths to date, and 1,000 more each day, America's life expectancy may appear to be plummeting. But in estimating the magnitude of the pandemic, University of California, Berkeley, demographers have found that CO

A quality improvement study led by the US FDA found that over 200 difficult-to-manufacture drug product samples met US standards for dosage unit uniformity and dissolution. The 252 products that were sampled in the largest such study to da

Pirate radio started out in England as a way to sidestep the regulations of Big Radio. While outlawed, it still exists today in the UK and America. 

AstraZeneca has begun testing an antibody-based cocktail for the prevention and treatment of COVID-19, adding to recent signs of progress on possible medical solutions to the disease caused by the novel coronavirus. The biopharma said the

In a business driven by profit, vaccines have a problem. They're not very profitable - at least not without government subsidies. Last year only four companies were making vaccines for the U.S. market, down from more than 20 in the 1970s.

A U.S. Patent Application for "Sensing Systems" was published by Georgia Tech on August 13th, 2020. The present invention is a thin, soft sensor array system that can be deployed over the surfaces of

Many diseases caused by bacterial infections -- such as pneumonia, meningitis or septicaemia -- are successfully treated with antibiotics. However, bacteria can develop resistance to antibiotics which then leaves doctors struggling to find

The US this week announced it will not begin collecting drug manufacturing volume data next month as required by the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). Section 3112 of the CARES Act establishes new reporting re

In this podcast two experts from Pall Biotech share their insights on the advantages, challenges and cost considerations associated with viral vector production.

Bristol Myers Squibb has entered into a definitive agreement to acquire Forbius, a privately held, clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases. Forb

A U.S. Patent Application for "Buffer Formulation Method and System" was published by Lonzaon August 13th, 2020. The present invention is a process for formulating buffer products for feeding to a bioprocess comprising:

Novartis has announced that the US FDA has approved Kesimpta® as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), to include clinically isolated syndrome, relapsing-remitting disease, and

On this episode of StarTalk Radio, Neil deGrasse Tyson and comic co-host Jordan Klepper are together again to answer fan-submitted Cosmic Queries about sharks. Since both Neil and Jordan are self-proclaimed non-experts on sharks, they're j

From MIT Video Productions comes "From Controversy to Cure," a 57-minute documentary history of the birth and boom of the molecular biology and biotechnology industries in Cambridge and specifically Kendall Square. Today, the area is